Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on cholesterol levels and atherosclerosis in ApoE-deficient mice
M. Van Eck et al., Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on cholesterol levels and atherosclerosis in ApoE-deficient mice, ART THROM V, 20(12), 2000, pp. 2600-2606
In the arterial wall, scavenger receptor class A (SRA) is implicated in pat
hological lipid deposition. In contrast, in the liver, SRA is suggested to
remove modified Lipoproteins from the circulation, thereby protecting the b
ody from their pathological action. The role of SRA on bone marrow-derived
cells in lipid metabolism and atherogenesis was assessed in vivo by transpl
antation of bone marrow cells overexpressing human SRA (MSR1) to apoE-defic
ient mice. In vitro studies with peritoneal macrophages from the transplant
ed mice showed that macrophage scavenger receptor function, as measured by
cell association and degradation studies with acetylated LDL, was approxima
te to3-fold increased on overexpression of MSR1 in bone marrow-derived cell
s as compared with control mice. Despite the increased macrophage scavenger
receptor function in vitro, no significant effect of MSRI overexpression i
n bone marrow-derived cells on the in vivo atherosclerotic lesion developme
nt was found. In addition to arterial wall macrophages, liver sinusoidal Ku
pffer cells also overexpress MSRI after bone marrow transplantation, which
may scavenge atherogenic particles more efficiently from the blood compartm
ent. Introduction of bone marrow cells over expressing human MSR1 in apoE-d
eficient mice induced a significant reduction in serum cholesterol levels o
f approximate to 20% (P<0.001, 2-way ANOVA) as the result of a decrease in
VLDL cholesterol. It is suggested that the reduction in VLDL cholesterol le
vels is due to increased clearance of modified Lipoproteins by the overexpr
essed MSR1 in Kupffer cells of the liver, thereby protecting the arterial w
all against the proatherogenic action of modified lipoproteins.